NIH-funded research R01 grant

Understanding how acetylation affects heart cell regeneration

Official title: Acetylation Regulates YAP Subcellular Localization and Cardiac Regeneration

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11042358 · Data updated 2026-11-12

This study is looking at how a protein called YAP helps heart cells heal after an injury, like a heart attack, and aims to find new ways to encourage these cells to grow and repair themselves better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$361,083
NIH project number1R01HL172839-01A1
Project IDNIH-11042358 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults suffering from ischemic heart diseases, particularly those who have experienced heart attacks or heart failure.

Less likely to help

Patients with non-ischemic heart conditions or those who are not adults may not benefit from this research.

What this research studies

This research investigates the role of acetylation in the localization of a protein called YAP, which is crucial for the regeneration of heart muscle cells after injury. By exploring how YAP moves in and out of the cell nucleus in response to various signals, the study aims to identify new therapeutic strategies to promote the natural division of heart cells, known as cardiomyocytes. The researchers will use animal models to understand the mechanisms behind YAP's function and how it can be manipulated to enhance heart repair following conditions like heart attacks.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart regeneration and recovery for patients with heart diseases.

How similar studies have gone: Previous studies have shown promising results in heart regeneration by targeting the Hippo pathway, indicating that this approach has potential based on earlier successes.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Liu, Shijie — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Liu, Shijie

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.